Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-5 of 5 (Search time: 0.009 seconds).
  • previous
  • 1
  • next
Item hits:
Issue DateTitleAuthor(s)
1-Sep-2016Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locusFeliubadaló i Elorza, Maria Lídia; Genetic Modifiers of Cancer Risk in BRCA1/2 Mutation Carriers (GEMO); Epidemiological study of BRCA1 & BRCA2 Mutation Carriers (EMBRACE); Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON); KConFab Investigators; Australian Ovarian Cancer Study Group
31-Dec-2014Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriersLázaro García, Conxi; Blanco Guillermo, Ignacio; Teulé-Vega, Àlex; Menéndez Vilà, Mireia; Epidemiological study of BRCA1 & BRCA2 Mutation Carriers (EMBRACE); Genetic Modifiers of Cancer Risk in BRCA1/2 Mutation Carriers (GEMO); Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON); KConFab Investigators
21-Jun-2016Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locusLázaro García, Conxi; Teulé-Vega, Àlex; Epidemiological study of BRCA1 & BRCA2 Mutation Carriers (EMBRACE); Genetic Modifiers of Cancer Risk in BRCA1/2 Mutation Carriers (GEMO); Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON); KConFab Investigators; AOCS Investigators
Apr-2016Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170Pujana Genestar, M. Ángel; EMBRACE Collaborators; GEMO Study Collaborators; Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON)
9-Feb-2016Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2Pujana Genestar, M. Ángel; KConFab Investigators; Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON); Epidemiological study of BRCA1 & BRCA2 Mutation Carriers (EMBRACE)